← Eichor
Study identifier: NCT06624046 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Circadian Mechanisms, Glucose, and CV Risks in T1D

Condition: Type 1 Diabetes (T1D)  ·  Sponsor: University of Illinois at Chicago

PhaseNA
Planned participants100
Who can joinAll sexes, 18 Years to 50 Years
Healthy volunteersNo

About this study

People with type 1 diabetes are disproportionately affected by cardiovascular disease (CVD). Short and irregular sleep have been associated with cardiovascular risk in this population. Improving sleep regularity has been associated with improved glycemic markers however mechanisms by which improving sleep regularity improves metabolic and cardiovascular health is not known. The investigators propose to conduct a mechanistic study using a sleep stability manipulation. This proposal will advance the understanding of mechanisms by which improving sleep regularity influences glycemic control and cardiovascular risk in T1D.

This description comes directly from the study's public registry record.

Talk to the study team

Pamela Martyn-Nemeth, PhD  ·  312-996-7903  ·  pmartyn@uic.edu

Sirimon Reutrakul, MD  ·  312-996-6060  ·  sreutrak@uic.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Illinois ChicagoChicago, Illinois, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06624046